Clinical Trials
12 trialsNCT05735717 2026-04-06
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT02298816 2024-10-03
HMvax-Regist
Wake Forest University Health Sciences
Withdrawn
NCT00965354 2024-09-19
MOSAIC
Imperial College London
Completed
NCT05818215 2023-04-18
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Pediatric Clinical Research Platform
Completed
NCT02108366 2019-10-21
Treatment of Severe Influenza A Infection
The University of Hong Kong
Phase 3 Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01924169 2018-09-20
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00307177 2014-12-05
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01707628 2014-01-31
Rituxivac
St. Antonius Hospital
Phase NA Completed
NCT00962715 2012-08-03
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT00307710 2012-07-31
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01016548 2010-06-04
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
University Health Network, Toronto
Phase 3 Completed